✦ LIBER ✦

A simple clinical approach to discriminate between “true” and “pseudo” secondary failure to oral hypoglycaemic agents

✍ Scribed by L. Scionti; P. Misericordia; A. Santucci; F. Santeusanio; P. Brunetti

Book ID: 104814549
Publisher: Springer
Year: 1992
Tongue: English
Weight: 514 KB
Volume: 29
Category: Article
ISSN: 0940-5429
DOI: 10.1007/bf00572824

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA phenotype and secondary failure to o

HLA phenotype and secondary failure to oral hypoglycaemic agents

✍ A. E. Pontiroli; A. Calderara; F. Capra; B. Fattor; M. T. Illeni; G. Pozza 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 263 KB

Supine catch sign—A simple clinical test

Supine catch sign—A simple clinical test to differentiate between true and false (pseudo) radial nerve palsy

✍ Nitin K. Sethi; Prahlad K. Sethi; Josh Torgovnick 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Comparison of NovoPen 3 and syringes/via

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents

✍ A Kadiri; A Chraibi; F Marouan; M.R Ababou; N El Guermai; A Wadjinny; A Kerfati; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Effects of a combination of bedtime inte

Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents

✍ M. Krempf; T. Godeau; S. Ranganathan; P. Blanchard; P. Ritz; B. Charbonnel 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 603 KB

The effect of a subcutaneous injection of an intermediate-acting insulin at bedtime combined with glibenclamide has been evaluated in 16 non-insulin-diabetic patients with secondary failure to respond to oral agents. The patients showed poor metabolic control (HbA1 greater than 11%) after two months

Efficacy of bedtime NPH insulin alone, a

Efficacy of bedtime NPH insulin alone, as compared to combination with metformin and/or glipizide in NIDDM patients with secondary failure on oral hypoglycaemic agents: R.J. Heine1, A. Scheen2, L. Van Gaal3, H. Schmitt4, P.S. van der Wal1 and the Benelux SWIM study group. 1Amsterdam, Netherlands; 2Liege, 3Antwerp, 4Brussels, Belgium

✍ Heine, R 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 200 KB